This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Camp, N. J. Articles by Cannon-Albright, L. A. Search for Related Content PubMed PubMed Citation Articles by Camp, N. J. Articles by Cannon-Albright, L. A.

Localization of a Prostate Cancer Predisposition Gene to an 880-kb Region on Chromosome 22q12.3 in Utah High-Risk Pedigrees

Division of Genetic Epidemiology, Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, Utah

Requests for reprints: Nicola J. Camp, Division of Genetic Epidemiology, Department of Biomedical Informatics, University of Utah School of Medicine, 391 Chipeta Way, Suite D, Salt Lake City, UT 84108. Phone: 801-587-9351; Fax: 801-581-6052; E-mail: nicola.camp{at}utah.edu.

Chromosome 22q has become recently a region of interest for prostate cancer. We identified previously a logarithm of odds (LOD) of 2.42 at chromosome 22q12.3. Additionally, this region has been noted by eight other studies, with linkage evidence ranging from LOD of 1.50 to 3.57. Here, we do fine mapping and localization of the region using a pedigree-specific recombinant mapping approach in 14 informative, high-risk Utah pedigrees. These 14 pedigrees were chosen because they were either "linked" or "haplotype-sharing" pedigrees or both. "Linked" pedigrees were those with significant pedigree-specific linkage evidence (LOD, >0.588; P < 0.05) to the 22q12.3 region, regardless of the number of prostate cancer cases sharing the segregating haplotype. "Haplotype-sharing" pedigrees were those with at least five prostate cancer cases sharing a segregating haplotype in the 22q12.3 region, regardless of the linkage evidence. In each pedigree, the most likely haplotype configuration (in addition to the multipoint LOD graph for linked pedigrees) was used to infer the position of recombinant events and delimit the segregating chromosomal segment in each pedigree. These pedigree-specific chromosomal segments were then overlaid to form a consensus recombinant map across all 14 pedigrees. Using this method, we identified a 881,538-bp interval at 22q12.3, between D22S1265 and D22S277, which is the most likely region that contains the 22q prostate cancer predisposition gene. The unique Utah extended high-risk pedigree resource allows this powerful localization approach in pedigrees with evidence for segregating predisposition to prostate cancer. We are mutation screening candidate genes in this region to identify specific genetic variants segregating in these pedigrees. (Cancer Res 2006; 66(20): 10205-12)

This article has been cited by other articles:

				J. P. Breyer, K. M. McReynolds, B. L. Yaspan, K. M. Bradley, W. D. Dupont, and J. R. Smith Genetic Variants and Prostate Cancer Risk: Candidate Replication and Exploration of Viral Restriction Genes Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 2137 - 2144. [Abstract] [Full Text] [PDF]

				E. A. Ostrander and M. S. Udler The Role of the BRCA2 Gene in Susceptibility to Prostate Cancer Revisited Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1843 - 1848. [Abstract] [Full Text] [PDF]

				N. J. Camp, L. A. Cannon-Albright, J. M. Farnham, A. B. Baffoe-Bonnie, A. George, I. Powell, J. E. Bailey-Wilson, J. D. Carpten, G. G. Giles, J. L. Hopper, et al. Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics Hum. Mol. Genet., June 1, 2007; 16(11): 1271 - 1278. [Abstract] [Full Text] [PDF]